Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neonatal Abstinence Syndrome | 4 | 2019 | 27 | 1.160 |
Why?
|
| Students, Medical | 3 | 2016 | 210 | 0.740 |
Why?
|
| Bibliotherapy | 1 | 2019 | 2 | 0.730 |
Why?
|
| Health Services Administration | 2 | 2012 | 11 | 0.690 |
Why?
|
| Cultural Competency | 2 | 2016 | 42 | 0.680 |
Why?
|
| Physician Executives | 3 | 2005 | 21 | 0.640 |
Why?
|
| Cultural Diversity | 1 | 2016 | 67 | 0.550 |
Why?
|
| Clinical Competence | 3 | 2016 | 657 | 0.520 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 148 | 0.500 |
Why?
|
| Health Facility Administrators | 1 | 2012 | 9 | 0.420 |
Why?
|
| Mentors | 1 | 2012 | 81 | 0.400 |
Why?
|
| Professional Competence | 3 | 2016 | 100 | 0.390 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 127 | 0.380 |
Why?
|
| Health Personnel | 2 | 2019 | 286 | 0.360 |
Why?
|
| South Carolina | 10 | 2022 | 2750 | 0.360 |
Why?
|
| Education, Medical | 2 | 2001 | 147 | 0.340 |
Why?
|
| Students, Nursing | 3 | 2016 | 101 | 0.330 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2019 | 99 | 0.320 |
Why?
|
| Rural Population | 3 | 2005 | 397 | 0.310 |
Why?
|
| Methadone | 2 | 2018 | 32 | 0.310 |
Why?
|
| Medicaid | 3 | 2019 | 301 | 0.300 |
Why?
|
| Rural Health Services | 2 | 2005 | 101 | 0.300 |
Why?
|
| Attitude of Health Personnel | 3 | 2016 | 442 | 0.280 |
Why?
|
| Insulin Resistance | 1 | 2008 | 241 | 0.280 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 33 | 0.270 |
Why?
|
| Health Occupations | 1 | 2005 | 28 | 0.270 |
Why?
|
| Rural Health | 1 | 2005 | 66 | 0.260 |
Why?
|
| Language | 2 | 2016 | 120 | 0.260 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 102 | 0.260 |
Why?
|
| Allied Health Personnel | 1 | 2005 | 37 | 0.250 |
Why?
|
| Competency-Based Education | 1 | 2005 | 32 | 0.250 |
Why?
|
| Bioterrorism | 1 | 2004 | 12 | 0.250 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 177 | 0.250 |
Why?
|
| Professional Role | 1 | 2005 | 80 | 0.250 |
Why?
|
| Physician's Role | 1 | 2005 | 116 | 0.240 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 261 | 0.240 |
Why?
|
| Nurse's Role | 1 | 2004 | 66 | 0.240 |
Why?
|
| Humans | 25 | 2023 | 68525 | 0.240 |
Why?
|
| United States | 11 | 2023 | 7335 | 0.240 |
Why?
|
| Education, Nursing | 1 | 2004 | 55 | 0.230 |
Why?
|
| Program Development | 1 | 2005 | 240 | 0.230 |
Why?
|
| Disaster Planning | 1 | 2004 | 105 | 0.230 |
Why?
|
| Quality of Health Care | 1 | 2005 | 322 | 0.220 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 581 | 0.220 |
Why?
|
| Vaccines | 1 | 2022 | 21 | 0.210 |
Why?
|
| Curriculum | 2 | 2012 | 575 | 0.210 |
Why?
|
| Self-Management | 1 | 2023 | 82 | 0.200 |
Why?
|
| Tamoxifen | 2 | 2019 | 62 | 0.200 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 1533 | 0.200 |
Why?
|
| Opiate Substitution Treatment | 2 | 2018 | 57 | 0.190 |
Why?
|
| Research Personnel | 1 | 2021 | 83 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 938 | 0.190 |
Why?
|
| Education, Graduate | 1 | 2000 | 30 | 0.190 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2019 | 11 | 0.180 |
Why?
|
| Communication | 2 | 2019 | 329 | 0.180 |
Why?
|
| Empathy | 1 | 2019 | 45 | 0.170 |
Why?
|
| Southeastern United States | 2 | 2016 | 281 | 0.160 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 498 | 0.150 |
Why?
|
| Medically Underserved Area | 3 | 2005 | 85 | 0.150 |
Why?
|
| Community Health Services | 1 | 2018 | 141 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 445 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 693 | 0.140 |
Why?
|
| Survivors | 1 | 2019 | 254 | 0.140 |
Why?
|
| Cost Savings | 1 | 2017 | 110 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 170 | 0.140 |
Why?
|
| Translating | 1 | 2016 | 23 | 0.140 |
Why?
|
| Culture | 1 | 2016 | 75 | 0.140 |
Why?
|
| Adult | 9 | 2023 | 21375 | 0.140 |
Why?
|
| Communication Barriers | 1 | 2016 | 48 | 0.140 |
Why?
|
| Surveys and Questionnaires | 3 | 2016 | 2798 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 154 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2018 | 335 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 209 | 0.130 |
Why?
|
| Transcultural Nursing | 1 | 2014 | 8 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2018 | 2453 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1085 | 0.120 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 106 | 0.110 |
Why?
|
| Young Adult | 4 | 2019 | 5708 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2264 | 0.110 |
Why?
|
| Female | 10 | 2019 | 38015 | 0.110 |
Why?
|
| Patient Care | 1 | 2012 | 61 | 0.110 |
Why?
|
| Health Education | 2 | 2012 | 279 | 0.100 |
Why?
|
| Medical Oncology | 1 | 2012 | 110 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2012 | 368 | 0.100 |
Why?
|
| Aromatase Inhibitors | 2 | 2019 | 17 | 0.080 |
Why?
|
| Male | 6 | 2016 | 37281 | 0.080 |
Why?
|
| Medically Uninsured | 2 | 2005 | 99 | 0.080 |
Why?
|
| Aged | 4 | 2023 | 14842 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2005 | 502 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 191 | 0.070 |
Why?
|
| Cultural Characteristics | 1 | 2005 | 42 | 0.070 |
Why?
|
| Organizational Case Studies | 1 | 2005 | 53 | 0.070 |
Why?
|
| Organizational Innovation | 1 | 2005 | 55 | 0.070 |
Why?
|
| Middle Aged | 5 | 2019 | 21119 | 0.070 |
Why?
|
| Anthrax | 1 | 2004 | 6 | 0.060 |
Why?
|
| Community Health Planning | 1 | 2004 | 19 | 0.060 |
Why?
|
| Models, Nursing | 1 | 2004 | 23 | 0.060 |
Why?
|
| Conflict of Interest | 1 | 2005 | 48 | 0.060 |
Why?
|
| Poverty | 1 | 2005 | 218 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2005 | 200 | 0.060 |
Why?
|
| Education, Professional | 1 | 2004 | 25 | 0.060 |
Why?
|
| Preceptorship | 1 | 2004 | 35 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 122 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2004 | 185 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 41 | 0.050 |
Why?
|
| Public Health | 1 | 2004 | 201 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 2004 | 0.050 |
Why?
|
| Government Programs | 1 | 2021 | 16 | 0.050 |
Why?
|
| Pregnancy | 2 | 2018 | 2331 | 0.050 |
Why?
|
| Attitude | 1 | 2022 | 121 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 110 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 285 | 0.050 |
Why?
|
| Self Care | 1 | 2023 | 252 | 0.050 |
Why?
|
| Time Factors | 1 | 2008 | 4655 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 955 | 0.040 |
Why?
|
| Diet | 1 | 2023 | 513 | 0.040 |
Why?
|
| Leadership | 1 | 2000 | 135 | 0.040 |
Why?
|
| Health Behavior | 1 | 2023 | 458 | 0.040 |
Why?
|
| Infant | 1 | 2005 | 2891 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 129 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2005 | 3185 | 0.040 |
Why?
|
| Rooming-in Care | 1 | 2018 | 2 | 0.040 |
Why?
|
| Child Protective Services | 1 | 2018 | 9 | 0.040 |
Why?
|
| SEER Program | 1 | 2018 | 150 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1582 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 567 | 0.040 |
Why?
|
| Health Resources | 1 | 2018 | 76 | 0.040 |
Why?
|
| Environment | 1 | 2018 | 115 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1609 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 92 | 0.040 |
Why?
|
| Models, Economic | 1 | 2017 | 69 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 389 | 0.040 |
Why?
|
| Urine | 1 | 2016 | 47 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 235 | 0.040 |
Why?
|
| Multilingualism | 1 | 2016 | 14 | 0.040 |
Why?
|
| Technology | 1 | 2016 | 24 | 0.040 |
Why?
|
| Cancer Survivors | 1 | 2018 | 145 | 0.030 |
Why?
|
| Comprehension | 1 | 2016 | 71 | 0.030 |
Why?
|
| Awareness | 1 | 2016 | 81 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2018 | 267 | 0.030 |
Why?
|
| Telephone | 1 | 2016 | 160 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 7264 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 563 | 0.030 |
Why?
|
| Child | 1 | 2005 | 6400 | 0.030 |
Why?
|
| Nursing Evaluation Research | 1 | 2014 | 46 | 0.030 |
Why?
|
| Nursing Education Research | 1 | 2014 | 35 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1265 | 0.030 |
Why?
|
| Patient Safety | 1 | 2016 | 202 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2018 | 413 | 0.030 |
Why?
|
| Adolescent | 1 | 2005 | 8903 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 711 | 0.030 |
Why?
|
| Focus Groups | 1 | 2012 | 247 | 0.030 |
Why?
|
| Prognosis | 1 | 2012 | 2093 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 3256 | 0.020 |
Why?
|
| Employee Performance Appraisal | 1 | 2004 | 12 | 0.020 |
Why?
|
| Mobile Health Units | 1 | 2004 | 18 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2004 | 59 | 0.010 |
Why?
|
| Educational Status | 1 | 2004 | 273 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2004 | 281 | 0.010 |
Why?
|
| Mammography | 1 | 2004 | 310 | 0.010 |
Why?
|
| Health Promotion | 1 | 2004 | 407 | 0.010 |
Why?
|
| Mass Screening | 1 | 2004 | 837 | 0.010 |
Why?
|